Graft-versus-leukemia for AKR spontaneous leukemia-lymphoma
- PMID: 11589
Item in Clipboard
Graft-versus-leukemia for AKR spontaneous leukemia-lymphoma
Transplant Proc.
1976 Dec.
Abstract
Adoptive immunotherapy in the form of a transient graft of mismatched DBA/2 BM + LN cells was used in combination with several chemoradiotherapy regimens to treat AKR mice bearing advanced SLL. Leukemic mice treated in this manner had a significant prolongation of their MST and significantly higher survival rates 60 and 90 days posttreatment than corresponding control groups. Syngeneic- or allogeneic-matched cells did not provide substantial GVL effect. An inverse relationship that influenced survival was observed between the radiation dose and the dose of GVL effector cells used to treat leukemic AKR mice in the treatment model. Recurrence leukemia remains a major problem.
Similar articles
-
Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease.Bone Marrow Transplant. 1993 Apr;11(4):329-36. Bone Marrow Transplant. 1993. PMID: 8485480
-
Graft-versus-leukemia effect in allogeneic bone marrow transplantation in mice against several radiation-induced leukemias.Bone Marrow Transplant. 1994 Feb;13(2):109-14. Bone Marrow Transplant. 1994. PMID: 8205078
-
Graft versus leukemia. 3. Apparent independent anthost and antileukemia activity of transplanted immunocompetent cells.Transplantation. 1973 Sep;16(3):182-8. Transplantation. 1973. PMID: 4147030 No abstract available.
-
Mouse leukemia and solid tumors treated with bone marrow grafting.Transplant Proc. 1976 Dec;8(4):565-7. Transplant Proc. 1976. PMID: 11588 Review. No abstract available.
-
Development of tumors as a result of graft-versus-host reaction.Exp Hematol. 1973;1(3):135-49. Exp Hematol. 1973. PMID: 4153858 Review. No abstract available.